Understanding the causes of varicose veins using stem cells
Official title: Stem Cell Model of Varicose Veins
Funded at Stanford University · NIH-10903198 · Data updated 2026-11-12
This study is looking into what causes varicose veins, a common issue for many adults, by using special cell models to understand how genes, inflammation, and blood flow work together, which could help find better ways to prevent and treat this condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $86,488 |
| NIH project number | 1F32HL170716-01A1 |
| Project ID | NIH-10903198 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adults experiencing symptoms of varicose veins or those with a family history of the condition.
✕Less likely to help
Patients who do not have varicose veins or related symptoms may not benefit from this research.
What this research studies
This research investigates the underlying mechanisms of varicose veins, a condition affecting many adults that can significantly impact quality of life. By utilizing stem cell models, the study aims to explore the genetic and epigenetic factors contributing to the development of varicose veins, as well as the role of inflammation and blood flow dynamics. The research will analyze how these factors interact at the cellular level, potentially leading to new insights into prevention and treatment strategies for this common condition.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment options for patients suffering from varicose veins.
How similar studies have gone: Previous research has identified genetic factors associated with varicose veins, suggesting that this approach may yield valuable insights into the condition.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Noishiki, Chikage — Stanford University
- Study coordinator: Noishiki, Chikage
Related research
Other NIH-funded projects on the same topics.
-
Multimodal AI to predict CAR-T patient response and guide safer, smarter cell design
A Stanford team is building AI tools that use patient and CAR-T cell data to predict how well a CAR-T therapy will work and what design changes might boost effectiveness and safety for people with cancer.
-
Community-driven model to reduce overdose deaths through smarter resource use
A Stanford-led project uses a data-driven model to help counties pick the best ways to prevent opioid and stimulant overdoses and save lives.
-
Center for Dissemination and Implementation at Stanford: Research Core
A Stanford-based program is advancing how evidence-based addiction treatments are implemented across settings to help people with substance use disorders receive better care.
-
Center for Dissemination and Implementation At Stanford (C-DIAS)
A center-based program at Stanford aims to speed people who need addiction treatments to get evidence-based care.
-
Mitochondrial structure and neuron health in Alzheimer's and ALS
This grant studies how mitochondrial cristae structure in neurons is controlled and how its disruption may contribute to diseases like Alzheimer's and ALS.
-
Pediatric EMS seizures: simpler age-based midazolam dosing
A nationwide trial at EMS agencies tests whether using fixed, age-based dosing of midazolam for seizures in children improves treatment speed and safety.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.